BluePrint Group suggested to governments of the world to incorporate the needed mental health treatment with co-infection in universal health coverage for better results.
Mental health stakeholders called the BluePrint Group during a webinar discussed Understanding HIV and Mental Health concluded that generally there needs to be more funding channeled to addressing mental health cases. BluePrint Group suggested to world governments that mental health should be covered by universal health coverage plans as addressing co-infections of either TB or HIV or both will address and eradicate the mental health cases.
Rutgers explained independently that TB/HIV coinfection usually results into depression, TB and mental health coinfection usually result into depression, anxiety and all other mental disorders are likely to occur and they are more rampant than TB/HIV coinfection.
“There is a clear bi-directional relationship of those with HIV, TB and mental health conditions.1 in 4 Sub-Sahara Africa is sick with a mental health condition and a chronic disease either TB or HIV. Co-infection with HIV may significantly increase the risk of depression by up to 70%. Integration of HIV, TB and mental health services should be part of universal health coverage. Addressing mental health from a TB perspective is critical to ending the epidemic,” Rutgers and Blue Print Group.
BluePrint Group argued that non-medical specialists are already providing treatment of co-infections of HIV/TB and mental health and it is effective that the governments offer such but traceable treatments in hospitals.
Co-infection of mental health, HIV and TB is described to be a difficult one because therapy is expected to treat the psychiatric complications considering the chronic infection HIV and TB role in a case of mental health because according to RUTGERS, mentally ill patients with HIV and TB in most cases are drug addicts and the source of exposure to multiple co-infections.
Co-infections need urgent treatment because it is a delicate balance to avoid extremely difficult unmanageable conditions such as drug resistance, failed treatment, death, and transmission to people in the environment while targeting to treat mental illness to improve other infection treatment outcomes through enhance adherence to completion of a treatment regimen.
The screening is recommended to be rigorous to avoid misdiagnosis in the complex situations where even with treatment for coinfection of chronic disease and mental illness the drug interaction is a concern and need additional medication to counter the adverse side effects which are bound to occur with the current medicines.
BluePrint Group advised health workers to ensure that proper screening systems should be in place to accurately diagnose mental health cases that occur with long –term chronic diseases of HIV and TB and quit the assumptions of socialization stigma and stereotypes of typical cases.
BluePrint Group proposed solutions such as incorporating community integration in treating mental health diseases and TB to build resilience and scale treatment, collaboration with WHO to implement the handbook of TB management in the community, designing of advocacy strategies to be used in the different cycles of TB, universal health coverage, use of the UN 90-90-90 campaign to end HIV/AIDS and work with 65% of the countries in the world willing to integrate mental health support services.
The Recover is an unbiased substance abuse and mental health news provider. Helping individuals looking for the right treatment programs in their area. Also providing information on drug rehab centers for addiction recovery.